CHEN, SINAN – Trademark Portfolio

Entity Type: 01

CHEN, SINAN owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ALPDOLF, CAKJUICE, and GAERUITE. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 24 (Fabrics) and Class 27 (Floor Coverings). Headquartered in PUTIAN, FUJIAN.

NO. 4, SHIWEI, SHIWEI VILLAGE,

DONGZHUANG, TOWN, XIUYU DISTRICT,

PUTIAN, FUJIAN , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ALPDOLF
ALPDOLF
Registered 2020
GAERUITE
GAERUITE
Registered 2020
CAKJUICE
CAKJUICE
Registered 2020

Trademark Classifications

CHEN, SINAN's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (1 filing)

Textiles and textile goods; bed covers; table covers

27
Floor Coverings (1 filing)

Carpets, rugs, mats and matting, linoleum and other materials for covering floors

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does CHEN, SINAN have?

CHEN, SINAN has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does CHEN, SINAN file in?

CHEN, SINAN files trademarks across 3 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 27 (Floor Coverings), Class 20 (Furniture). Class 24 covers textiles and textile goods; bed covers; table covers.

What are CHEN, SINAN's most well-known trademarks?

CHEN, SINAN's registered trademark portfolio includes well-known marks such as ALPDOLF, CAKJUICE, and GAERUITE. These are among 3 currently registered trademarks in the portfolio.

What is CHEN, SINAN's trademark registration success rate?

CHEN, SINAN has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.